The Signal Directory
Founders, investors, health system and payer leaders, policy people and analysts. Filter by the part of the industry they work in and where they post.
Looking for practising clinicians instead? Open the clinician directory.
Resident Fellow, American Enterprise Institute
He delivers timely analysis of drug development pipelines, FDA approval processes, and public health policy. His commentary covers market access trends and pharmaceutical industry updates.
FDA Approval / Drug Development / Public Health Policy
Best for: Biotech executives, investors, and public health analysts.
Director, Duke-Margolis Institute for Health Policy
Provides authoritative discussions on payment models, healthcare delivery reform, and real-world evidence. He offers insights into policies advancing health equity and high-value care systems.
Payment Reform / Healthcare Quality / Real-World Evidence
Best for: Healthcare economists and system administrators.
Co-Founder and CEO, Aledade
Offers invaluable analysis on healthcare delivery reform, value-based care policy, and primary care enablement. He regularly shares practical advice on navigating Medicare rules and clinical workflows.
Value-Based Care / Medicare Reform / Primary Care Policy
Best for: Primary care clinicians and digital health operators.
Venture Partner and Nonresident Fellow, Brookings Institution
Follow for expert breakdowns of healthcare legislative reform, physician payment policies, and community medicine programs. She delivers pragmatic updates on federal health programs and policy implementation.
Healthcare Reform / Medicare Policy / Physician Payments
Best for: Health policy researchers and clinical executives.
National Coordinator for Health IT, HHS Office of the National Coordinator
He provides authoritative updates on national electronic health record interoperability standards, health IT policies, and federal digital health strategies aiming to improve patient access.
Interoperability / Health IT Standards / Patient Data Access
Best for: Health IT developers and clinical informatics leaders.
Venture Partner, ARCH Venture Partners
Provides expert insights on global health security, FDA drug regulation, and pandemic preparedness. Her posts offer deep analysis of national health policies and medical countermeasures.
FDA Drug Regulation / Biosecurity / Pandemic Preparedness
Best for: Healthcare investors, biosecurity analysts, and policy makers.
Director, ARPA-H
Leads ARPA-H and its high-risk health research portfolio, including programs advancing computational and non-animal approaches to drug development.
Biomedical innovation / Drug development / Federal research
Best for: Health policy and research leaders
Acting Commissioner of Food and Drugs, US Food and Drug Administration
Leads the FDA as it updates regulations supporting validated non-animal and computational methods in nonclinical development.
FDA policy / Regulation / Nonclinical testing
Best for: Regulatory and life sciences leaders
Director, ARPA-H
Directs the federal agency funding high-risk health programs including the $62.7M ADVOCATE autonomous clinical AI initiative.
Biomedical innovation / Clinical AI policy / Federal research funding
Best for: Leaders tracking federal health innovation funding and policy
Health Privacy and Regulatory Consultant, Devici Group
Follow for essential updates on HIPAA regulations, health data privacy laws, and patient data rights. She translates complex legal frameworks into actionable strategies for digital health teams.
HIPAA Privacy / Health Data Privacy / Data Sharing Rights
Best for: Compliance officers, lawyers, and digital health founders.
Board-Certified Patient Advocate, Enlightening Results
Shares critical commentary on digital health equity, information blocking rules, and patient access to records. She champions administrative burden reduction from a patient perspective.
Digital Health Equity / Information Blocking / Patient Advocacy
Best for: Patient advocates and health technology designers.
Chief Administration and Legal Officer, Omada Health
Offers deep expertise on digital health regulation, privacy compliance, and health data sharing models. She regularly posts on federal regulatory frameworks affecting digital therapeutics.
Digital Health Law / Privacy Compliance / Federal Frameworks
Best for: Digital health executives and regulatory compliance teams.
Assistant Professor of Law, Saint Louis University School of Law
Follow for detailed analysis of FDA regulations, pharmaceutical law, and drug pricing. He provides regular, expert commentary on public health legal updates and regulatory decisions.
FDA Regulation / Pharmaceutical Law / Drug Pricing
Best for: Legal professionals and pharmaceutical developers.
Showing 13 of 190 people. Listings are editorial, not paid, and nobody pays to appear here.
